home / stock / bpts / bpts news

BPTS News and Press, Biophytis SA From 08/08/23

Stock Information
Company Name: Biophytis SA
Stock Symbol: BPTS
Market: NASDAQ
Menu
BPTS BPTS Quote BPTS Short BPTS News BPTS Articles BPTS Message Board
Get BPTS Alerts

News, Short Squeeze, Breakout and More Instantly...
BPTS - Biophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europe

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / August 8, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with agin...
BPTS - NKLA, RAD and ELAN are among pre market gainers

2023-08-07 08:34:22 ET Missfresh ( MF ) +51% a nnounces Entry into Share Transfer Agreement. Sequans Communications  ( SQNS ) +31% Q2 earnings call release Tabula Rasa HealthCare ( TRHC ) +30% Reports Second Quarter 2023 Financial Results. ...

BPTS - FVRR, CHRS and NVBSE are among pre market gainers

2023-08-03 08:46:55 ET Traeger ( COOK ) +28% . NeuBase Therapeutics ( NBSE ) +21% . Upwork  ( UPWK ) +17% Q2 earningas call release Biophytis ( BPTS ) +16% . Interactive Strength ( TRNR ) +16% Announces Distribution Partnershi...

BPTS - COLB, ONDS and COSM among pre-market losers

2023-07-20 08:29:22 ET Netcapital NCPL -42% on $1.2M equity offering . Gossamer Bio ( GOSS ) -21% announces $212 Million private placement financing . DURECT Corporation ( DRRX ) -19% announces $15 Million Registered Direct Offering . Jianzhi Ed...
BPTS - Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / July 20, 2023 / Biophytis SA (Nasdaq CM:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with agi...

BPTS - TOST, GP and GNPX among pre-market losers

2023-07-19 08:30:52 ET Aqua Metals ( AQMS ) -27% after disclosing stock offering . Amarin Corporation ( AMRN ) -20% on plan to undergo restructuring . Biophytis ( BPTS ) -18% on $3.8M offering . Genprex ( GNPX ) -14% on $7.5 Millio...

BPTS - Biophytis down 12% on $3.8M offering

2023-07-19 06:34:45 ET Clinical-stage biotechnology company, Biophytis ( NASDAQ: BPTS ) stock price jumps 13% as the company enters purchase and sale of 1.33M units , each consisting of one ADS or one prefunded warrant giving right to one ADS. Each ADS represents ...
BPTS - Biophytis Announces $3.8 Million Registered Direct Offering

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / July 19, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associat...

BPTS - iCAD, Biophytis top healthcare gainers; Lixte, Masimo lead losers pack

2023-07-18 10:13:56 ET Gainers: iCAD ( ICAD ) +31% . Biophytis ( BPTS ) +27% . Hyperfine ( HYPR ) +15% . Cabaletta Bio ( VERU ) +12% . Mind Medicine (MindMed) ( MNMD ) +10% . Losers: Lixte Biotechnology ( LIXT ) ...

BPTS - Biophytis and SEQENS will together produce Sarconeos active compound

2023-07-18 07:11:17 ET Clinical-stage biotechnology company, Biophytis SA ( NASDAQ: BPTS ) and SEQENS concluded a master agreement for the production of the active compound in Sarconeos (BIO101), Biophytis' main drug candidate developed for three indications: severe forms of Cov...
Previous 10 Next 10